Suppr超能文献

碘克沙醇用于股动脉造影(III期):碘克沙醇与碘普罗胺的双盲平行对照试验

Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide.

作者信息

Pugh N D, Sissons G R, Ruttley M S, Berg K J, Nossen J O, Eide H

机构信息

Department of Medical Physics, University Hospital of Wales, Cardiff, UK.

出版信息

Clin Radiol. 1993 Feb;47(2):96-9. doi: 10.1016/s0009-9260(05)81180-8.

Abstract

Iodixanol is a new non-ionic, dimeric contrast medium (CM) which is formulated to be isotonic with blood in all clinically relevant concentrations. This is a report of a parallel, double-blind study comparing the safety and efficacy of iodixanol with iopromide (Ultravist) in aortofemoral arteriography. One hundred consecutive, eligible patients scheduled to undergo peripheral arteriography were entered into the study and randomly allocated to receive one or other CM. Radiographic quality, discomfort, adverse events, femoral blood flow and renal function were examined. Ninety-five patients were successfully included in the study. Radiographic quality (efficacy) was found to be similar in both groups. Three patients (6%) in the iodixanol group and five patients (11%) in the iopromide group reported adverse events. In this respect there was no statistically significant difference between the two groups (P = 0.48), and all adverse events were mild and transient. Forty-six (97%) patients in the iodixanol group and 45 (100%) patients in the iopromide group experienced a sensation of warmth (discomfort) in connection with one or more of the injections. There was no statistically significant difference in the frequency of discomfort in the two groups. However, the intensity of warmth was significantly milder following iodixanol than after iopromide (P = 0.003, two-sided Mantel-Haenszel test). The mean percentage increase in femoral blood flow was found to be less with iodixanol (43.4%) than with iopromide (96.3%) (P < 0.05, Student's t-test). Renal function was affected slightly after administration of both CM. Serum creatinine and creatinine clearance were affected more by iodixanol than by iopromide, while the excretion of tubular enzymes was more affected by iopromide. In conclusion, this comparison between iodixanol and iopromide showed both contrast media to be safe, effective and well tolerated and the only major difference between them was in their effect on femoral blood flow.

摘要

碘克沙醇是一种新型非离子二聚体造影剂(CM),其在所有临床相关浓度下均与血液等渗。本文报告了一项平行双盲研究,比较碘克沙醇与碘普罗胺(优维显)在腹主动脉-股动脉造影中的安全性和有效性。连续100例计划接受外周动脉造影的合格患者进入研究,并随机分配接受其中一种造影剂。检查了影像质量、不适情况、不良事件、股动脉血流和肾功能。95例患者成功纳入研究。发现两组的影像质量(有效性)相似。碘克沙醇组有3例患者(6%)报告不良事件,碘普罗胺组有5例患者(11%)报告不良事件。在这方面,两组之间无统计学显著差异(P = 0.48),且所有不良事件均为轻度且短暂。碘克沙醇组46例(97%)患者和碘普罗胺组45例(100%)患者在一次或多次注射时有温热感(不适)。两组不适频率无统计学显著差异。然而,碘克沙醇注射后温热感强度明显低于碘普罗胺(P = 0.003,双侧Mantel-Haenszel检验)。发现碘克沙醇使股动脉血流平均增加百分比(43.4%)低于碘普罗胺(96.3%)(P < 0.05,Student t检验)。两种造影剂给药后肾功能均受到轻微影响。碘克沙醇对血清肌酐和肌酐清除率的影响大于碘普罗胺,而碘普罗胺对肾小管酶排泄的影响更大。总之,碘克沙醇与碘普罗胺的比较表明两种造影剂均安全、有效且耐受性良好,它们之间唯一的主要差异在于对股动脉血流的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验